Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
ARUP Laboratories, |
RCV000506833 | SCV000605462 | pathogenic | not specified | 2016-09-01 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000793317 | SCV000932665 | pathogenic | Tuberous sclerosis 2 | 2024-04-22 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Gln1714*) in the TSC2 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in TSC2 are known to be pathogenic (PMID: 10205261, 17304050). This variant is not present in population databases (gnomAD no frequency). This premature translational stop signal has been observed in individual(s) with TSC2-related conditions (PMID: 21520333). ClinVar contains an entry for this variant (Variation ID: 49351). For these reasons, this variant has been classified as Pathogenic. |
Genome- |
RCV000793317 | SCV002041018 | pathogenic | Tuberous sclerosis 2 | 2021-11-07 | criteria provided, single submitter | clinical testing | |
Tuberous sclerosis database |
RCV000042611 | SCV000066405 | not provided | Tuberous sclerosis syndrome | no assertion provided | curation |